Oxford University has been ranked as the world’s best institution for medical and health teaching and research for the ninth consecutive year in the latest Times Higher Education World University Rankings. © John Cairns & Fisher Studios The subject-specific tables for clinical, pre-clinical and health studies follow on from the announcement that Oxford has been […]
Analysis of antipsychotic drugs could improve outcomes for schizophrenia patients Results of a new study published in The Lancet this month will help doctors to balance the benefits and side-effects of medication they prescribe to treat schizophrenia. Schizophrenia is one of the most common psychiatric disorders in adults worldwide – one in 100 people globally […]
Oxford Brookes University will receive a share of £20 million from the UK government to help stimulate growth in the local economy, it has been announced today (Friday 20 September). The investment will see the launch of twenty University Enterprise Zones (UEZs) throughout the UK, which will strengthen collaborative ties between universities and businesses and […]
Healthcare staff in Thames Valley and South Midlands were honoured for their contribution to NHS, public health and social care research at an awards event in Reading last night (26 September 2019). The fourth Thames Valley Health Research Awards was held in Reading Town Hall and organised by the NIHR Clinical Research Network Thames Valley […]
Sobell House’s new extension was officially opened yesterday (Monday 30 September 2019) by Chair of Oxford University Hospitals NHS Foundation Trust, Professor Sir Jonathan Montgomery. The hospice, on the Churchill Hospital site, now has a two-storey extension housing a specialist outpatient facility (the Sobell Clinic) and a six-patient ward (the Garden Annex) designed to support […]
In October 2017 Oxford University Hospitals (OUH), the University of Oxford and Mayo Clinic announced a new partnership, agreeing to work together to drive advances in medical research and patient care. The multi-award-winning US-based Mayo Clinic serves more than 1.3 million patients worldwide, and invests more than $1bn in clinical research and education each year. In October 2019 […]
Two Medical Sciences researchers are amongst the seven successful applicants to have been chosen as the 2019-20 cohort of Public Engagement with Research (PER) Leaders. Dr Katharine Owen (OCDEM, Radcliffe Department of Medicine) and Dr Sean Elias (Jenner Institute, Nuffield Department of Medicine) are two of only seven researchers to be chosen in the 2019-20 cohort of Public Engagement with Research […]
The new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic […]
Oxford Brain Diagnostics, a spinout from Oxford University, has been launched to deliver a new method for diagnosing Alzheimer’s Disease from MRI scans. The company is already engaged with pharmaceutical and biotech companies to help support them to accelerate the development of effective new drugs and treatments for Alzheimer’s Disease. The company will develop its […]
Six new Oxford-Celgene Fellowships will support postdoctoral researchers and clinicians across six departments within the Medical Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development. The new Fellowships represent an additional investment of £3M into the University. The Oxford-Celgene Fellowship Programme was established in 2015 with the […]